QuantumPharm, Inc. (HK:2228) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
QuantumPharm Inc. has released its interim financial results for the first half of 2024, revealing a significant loss of RMB 1,237,550,000, almost double from the previous year’s RMB 620,297,000. Despite an increase in revenue to RMB 102,630,000 from RMB 79,967,000, the company’s research and development expenses and other costs contributed to the overall loss. The report indicates a challenging period for QuantumPharm, with the company urging caution regarding forward-looking statements.
For further insights into HK:2228 stock, check out TipRanks’ Stock Analysis page.